SCHEMBL27259618

SCHEMBL27259618

COCc1nc(C)c(C(C)=O)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.54
▸ RXFP1 Q9HBX9 3/20 0.44
▸ TSHR P16473 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ RAB9A P51151 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ GSK3A P49840 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MAPT P10636 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9120822 0.87 ALDH1A1 (0.50) ALDH1A1TSHRGAARAB9ASMN1; SMN2
SCHEMBL3274867 0.83 ALDH1A1 (0.54) ALDH1A1RXFP1TSHRCYP1A2RAB9A
SCHEMBL9850884 0.75 SMN1; SMN2 (0.36) ALDH1A1TSHRCYP1A2GAACYP2C9
SCHEMBL19002526 0.74 POLB (0.42) ALDH1A1SMN1; SMN2MAPT
SCHEMBL2300954 0.74 RAB9A (0.60) ALDH1A1RXFP1GAARAB9ASMN1; SMN2
SCHEMBL9643824 0.73 SMN1; SMN2 (0.36) ALDH1A1TSHRGAACYP2C9RAB9A
SCHEMBL3274275 0.72 POLB (0.37) ALDH1A1SMN1; SMN2MAPT
SCHEMBL211358 0.71 RXFP1 (0.50) ALDH1A1RXFP1TSHRCYP1A2GAA
SCHEMBL27673868 0.71 POLB (0.39) SMN1; SMN2MAPT
SCHEMBL24271761 0.71 ALDH1A1 (0.41) ALDH1A1RXFP1CYP1A2GAACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026484-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
WO-2024026483-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
WO-2024026479-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback